Health Care Equipment & Services

BDX tops Q3 2026 expectations, boosting revenue and EPS guidance while solidifying cash flow and shareholder value.

Hedera Group AB’s tokenization partnership with Taurus and Sibos Miami showcase shows how the Stockholm‑based staffing firm is pivoting toward blockchain‑enabled healthcare finance, promising new revenue streams and institutional adoption.

WELL Health Technologies Q2 2026: Record $400 M revenue, 32% jump, new digital‑led leadership, but earnings miss—investor focus on cost control and future growth.

Avricore Health Inc. focuses on distributing generic and over‑the‑counter pharmaceuticals, trading at CAD 0.055 with a negative P/E ratio—investors weigh its growth potential in affordable healthcare.

Teladoc Health faces a securities fraud probe amid steep share drop, with investors urged to seek legal help as the company battles earnings miss and regulatory scrutiny.

VitalHub Corp reports Q2 2026 results, launches a normal course issuer bid, and outlines plans to strengthen its health‑tech platform and capital position.

Concentra Group Holdings’ Rule 144 filing: 380k shares sold by director Robert A. Ortenzio, compliant with SEC rules, revealing key insider activity in the healthcare sector.

Profound Medical Corp. leads the way in localized prostate cancer treatments, combining cutting‑edge tech with a global reach to improve patient outcomes.

Talkspace: transforming mental health with affordable, tech‑driven online therapy, medication management, and licensed support—boosting accessibility and destigmatizing care.

Discover how Sintx Technologies uses silicon nitride to pioneer spinal fusion and joint‑replacement devices, balancing growth, volatility, and U.S. market focus.